Logo image of NRGX

PIMCO ENRGY & TACT CRDT OPP (NRGX) Stock Overview

USA - NYSE:NRGX - US69346N1072

20.26 USD
+0.2 (+1%)
Last: 11/20/2023, 8:26:40 PM
Fundamental Rating

2

Taking everything into account, NRGX scores 2 out of 10 in our fundamental rating. NRGX was compared to 0 industry peers in the Unkown industry. Both the profitability and financial health of NRGX have multiple concerns. NRGX is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year NRGX was profitable.
NRGX had a negative operating cash flow in the past year.
NRGX Yearly Net Income VS EBIT VS OCF VS FCFNRGX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 0 -500M -1B

1.2 Ratios

Industry RankSector Rank
ROA 13.4%
ROE 18.88%
ROIC 1.34%
ROA(3y)-13.16%
ROA(5y)N/A
ROE(3y)-18.07%
ROE(5y)N/A
ROIC(3y)2.34%
ROIC(5y)N/A
NRGX Yearly ROA, ROE, ROICNRGX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 0 -50 -100

1.3 Margins

In the last couple of years the Profit Margin of NRGX has grown nicely.
In the last couple of years the Operating Margin of NRGX has grown nicely.
In the last couple of years the Gross Margin of NRGX has grown nicely.
Industry RankSector Rank
OM 52.45%
PM (TTM) 425.46%
GM 51.85%
OM growth 3Y3.66%
OM growth 5YN/A
PM growth 3Y32.32%
PM growth 5YN/A
GM growth 3Y3.55%
GM growth 5YN/A
NRGX Yearly Profit, Operating, Gross MarginsNRGX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 0 500 -500 1K -1K

More info and screens

1

2. Health

2.1 Basic Checks

Compared to 1 year ago, NRGX has about the same amount of shares outstanding.
NRGX has a worse debt/assets ratio than last year.
NRGX Yearly Shares OutstandingNRGX Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 10M 20M 30M 40M
NRGX Yearly Total Debt VS Total AssetsNRGX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 200M 400M 600M 800M 1B

2.2 Solvency

Based on the Altman-Z score of 1.54, we must say that NRGX is in the distress zone and has some risk of bankruptcy.
A Debt/Equity ratio of 0.37 indicates that NRGX is not too dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.37
Debt/FCF N/A
Altman-Z 1.54
ROIC/WACCN/A
WACCN/A
NRGX Yearly LT Debt VS Equity VS FCFNRGX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 0 500M -500M -1B

2.3 Liquidity

NRGX has a Current Ratio of 0.42. This is a bad value and indicates that NRGX is not financially healthy enough and could expect problems in meeting its short term obligations.
A Quick Ratio of 0.42 indicates that NRGX may have some problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 0.42
Quick Ratio 0.42
NRGX Yearly Current Assets VS Current LiabilitesNRGX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 100M 200M 300M 400M

More info and screens

4

3. Growth

3.1 Past

The earnings per share for NRGX have decreased strongly by -42.98% in the last year.
Measured over the past years, NRGX shows a very strong growth in Earnings Per Share. The EPS has been growing by 51.85% on average per year.
NRGX shows a strong growth in Revenue. In the last year, the Revenue has grown by 37.79%.
The Revenue has been growing by 14.87% on average over the past years. This is quite good.
EPS 1Y (TTM)-42.98%
EPS 3Y51.85%
EPS 5YN/A
EPS Q2Q%112.32%
Revenue 1Y (TTM)37.79%
Revenue growth 3Y14.87%
Revenue growth 5YN/A
Sales Q2Q%26.79%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
NRGX Yearly Revenue VS EstimatesNRGX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 10M 20M 30M 40M

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 6.01, the valuation of NRGX can be described as very cheap.
NRGX is valuated cheaply when we compare the Price/Earnings ratio to 27.54, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 6.01
Fwd PE N/A
NRGX Price Earnings VS Forward Price EarningsNRGX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
NRGX Per share dataNRGX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

5

5. Dividend

5.1 Amount

NRGX has a Yearly Dividend Yield of 5.73%, which is a nice return.
Compared to an average S&P500 Dividend Yield of 2.41, NRGX pays a better dividend.
Industry RankSector Rank
Dividend Yield 5.73%

5.2 History

The dividend of NRGX is nicely growing with an annual growth rate of 30.84%!
NRGX has been paying a dividend for over 5 years, so it has already some track record.
The dividend of NRGX decreased recently.
Dividend Growth(5Y)30.84%
Div Incr Years1
Div Non Decr Years1
NRGX Yearly Dividends per shareNRGX Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 0.2 0.4 0.6 0.8 1

5.3 Sustainability

24.61% of the earnings are spent on dividend by NRGX. This is a low number and sustainable payout ratio.
DP24.61%
EPS Next 2YN/A
EPS Next 3YN/A
NRGX Yearly Income VS Free CF VS DividendNRGX Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2019 2020 2021 2022 0 -500M -1B
NRGX Dividend Payout.NRGX Dividend Payout, showing the Payout Ratio.NRGX Dividend Payout.PayoutRetained Earnings

More info and screens

PIMCO ENRGY & TACT CRDT OPP

NYSE:NRGX (11/20/2023, 8:26:40 PM)

20.26

+0.2 (+1%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners51.04%
Inst Owner Change-10.43%
Ins Owners6.08%
Ins Owner Change0%
Market Cap905.82M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 5.73%
Yearly Dividend0.73
Dividend Growth(5Y)30.84%
DP24.61%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 6.01
Fwd PE N/A
P/S 25.57
P/FCF N/A
P/OCF N/A
P/B 1.13
P/tB 1.13
EV/EBITDA N/A
EPS(TTM)3.37
EY16.63%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-1.56
FCFYN/A
OCF(TTM)-1.56
OCFYN/A
SpS0.79
BVpS17.86
TBVpS17.86
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 13.4%
ROE 18.88%
ROCE 2.32%
ROIC 1.34%
ROICexc 1.35%
ROICexgc 1.37%
OM 52.45%
PM (TTM) 425.46%
GM 51.85%
FCFM N/A
ROA(3y)-13.16%
ROA(5y)N/A
ROE(3y)-18.07%
ROE(5y)N/A
ROIC(3y)2.34%
ROIC(5y)N/A
ROICexc(3y)2.36%
ROICexc(5y)N/A
ROICexgc(3y)2.4%
ROICexgc(5y)N/A
ROCE(3y)3.32%
ROCE(5y)N/A
ROICexcg growth 3Y31.74%
ROICexcg growth 5YN/A
ROICexc growth 3Y31.69%
ROICexc growth 5YN/A
OM growth 3Y3.66%
OM growth 5YN/A
PM growth 3Y32.32%
PM growth 5YN/A
GM growth 3Y3.55%
GM growth 5YN/A
F-Score4
Asset Turnover0.03
Health
Industry RankSector Rank
Debt/Equity 0.37
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 6.38
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.42
Quick Ratio 0.42
Altman-Z 1.54
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-42.98%
EPS 3Y51.85%
EPS 5YN/A
EPS Q2Q%112.32%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)37.79%
Revenue growth 3Y14.87%
Revenue growth 5YN/A
Sales Q2Q%26.79%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y18.39%
EBIT growth 3Y19.07%
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-114.3%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-114.3%
OCF growth 3YN/A
OCF growth 5YN/A